Abstract
B-cell maturation antigen (BCMA) is a target for the treatment of multiple myeloma with cytolytic therapies, such as chimeric antigen receptor T-cells......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
